1-16 of 16
Jorge E. Cortes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding

Jorge E. Cortes, Elisabetta Abruzzese, Elyce H. Cardonick, Sonia Hernández-Díaz, Jamie Gutierrez, Mary S. Sardegna, Erica Torres-Chavez, Miriam Dinatale, Catherine C. Lerro, Brenda J. Gehrke, Stacy S. Shord, R. Angelo De Claro, Marc R. Theoret, Peter J. DeMaria, Kelly J. Norsworthy
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (17): 3658–3666.
https://doi.org/10.1158/1078-0432.CCR-24-0826
Published: 03 September 2024
View article titled, Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding
Open the PDF for Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding in another window
Journal Articles

Project Confirm: Accelerated Drug Approvals for CML—Response

Kendra L. Sweet, Jorge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler, Cristina Ruiz, Charles A. Schiffer, Lori A. Ehrlich, Gulsum E. Pamuk, Joseph Wynne, Gautam U. Mehta, Olanrewaju O. Okusanya, R. Angelo de Claro, Marc R. Theoret, B. Douglas Smith, Kelly J. Norsworthy
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (1): 237–238.
https://doi.org/10.1158/1078-0432.CCR-23-3234
Published: 05 January 2024
View article titled, Project Confirm: Accelerated Drug Approvals for CML—Response
Open the PDF for Project Confirm: Accelerated Drug Approvals for CML—Response in another window
Journal Articles

Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia

Kendra L. Sweet, Jorge E. Cortes, Jane F. Apperley, Mel Mann, Michael J. Mauro, Vivian G. Oehler, Cristina Ruiz, Charles A. Schiffer, Lori A. Ehrlich, Gulsum E. Pamuk, Joseph Wynne, Gautam U. Mehta, R. Angelo de Claro, Marc R. Theoret, B. Douglas Smith, Kelly J. Norsworthy
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (12): 2179–2183.
https://doi.org/10.1158/1078-0432.CCR-22-2628
Published: 13 June 2023
View article titled, Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia
Open the PDF for Project Confirm: Accelerated Drug Approvals for Chronic Myeloid Leukemia in another window
Journal Articles

Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS

Michael R. Savona, Daniel A. Pollyea, Wendy Stock, Vivian G. Oehler, Mark A. Schroeder, Jeffrey Lancet, James McCloskey, Hagop M. Kantarjian, Weidong Wendy Ma, M. Naveed Shaik, A. Douglas Laird, Mirjana Zeremski, Ashleigh O'Connell, Geoffrey Chan, Jorge E. Cortes
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (10): 2294–2303.
https://doi.org/10.1158/1078-0432.CCR-17-2824
Published: 14 May 2018
View article titled, Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS
Open the PDF for Phase Ib Study of Glasdegib, a Hedgehog Pathway Inhibitor, in Combination with Standard Chemotherapy in Patients with AML or High-Risk MDS in another window
Includes: Supplementary data
Journal Articles

Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models

Juliana Benito, Marc S. Ramirez, Niki Zacharias Millward, Juliana Velez, Karine G. Harutyunyan, Hongbo Lu, Yue-xi Shi, Polina Matre, Rodrigo Jacamo, Helen Ma, Sergej Konoplev, Teresa McQueen, Andrei Volgin, Marina Protopopova, Hong Mu, Jaehyuk Lee, Pratip K. Bhattacharya, Joseph R. Marszalek, R. Eric Davis, James A. Bankson, Jorge E. Cortes, Charles P. Hart, Michael Andreeff, Marina Konopleva
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (7): 1687–1698.
https://doi.org/10.1158/1078-0432.CCR-14-3378
Published: 31 March 2016
View article titled, Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
Open the PDF for Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models in another window
Includes: Supplementary data
Journal Articles

Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens

Katja Karjalainen, Diana E. Jaalouk, Carlos Bueso-Ramos, Laura Bover, Yan Sun, Akihiko Kuniyasu, Wouter H.P. Driessen, Marina Cardó-Vila, Cecilia Rietz, Amado J. Zurita, Susan O'Brien, Hagop M. Kantarjian, Jorge E. Cortes, George A. Calin, Erkki Koivunen, Wadih Arap, Renata Pasqualini
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (13): 3041–3051.
https://doi.org/10.1158/1078-0432.CCR-13-3059
Published: 30 June 2015
View article titled, Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens
Open the PDF for Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens in another window
Includes: Supplementary data
Journal Articles

Reversal of Acquired Drug Resistance in FLT3-Mutated Acute Myeloid Leukemia Cells via Distinct Drug Combination Strategies

Weiguo Zhang, Chen Gao, Marina Konopleva, Ye Chen, Rodrigo O. Jacamo, Gautam Borthakur, Jorge E. Cortes, Farhad Ravandi, Abhijit Ramachandran, Michael Andreeff
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2363–2374.
https://doi.org/10.1158/1078-0432.CCR-13-2052
Published: 30 April 2014
View article titled, Reversal of Acquired Drug Resistance in <em>FLT3</em>-Mutated Acute Myeloid Leukemia Cells via Distinct Drug Combination Strategies
Open the PDF for Reversal of Acquired Drug Resistance in <em>FLT3</em>-Mutated Acute Myeloid Leukemia Cells via Distinct Drug Combination Strategies in another window
Includes: Supplementary data
Journal Articles

Omacetaxine: A Protein Translation Inhibitor for Treatment of Chronic Myelogenous Leukemia

Varsha Gandhi, William Plunkett, Jorge E. Cortes
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (7): 1735–1740.
https://doi.org/10.1158/1078-0432.CCR-13-1283
Published: 31 March 2014
View article titled, Omacetaxine: A Protein Translation Inhibitor for Treatment of Chronic Myelogenous Leukemia
Open the PDF for Omacetaxine: A Protein Translation Inhibitor for Treatment of Chronic Myelogenous Leukemia in another window
Journal Articles

Second-Generation Tyrosine Kinase Inhibitors: The Future of Frontline CML Therapy

Hagop M. Kantarjian, Michele Baccarani, Elias Jabbour, Giuseppe Saglio, Jorge E. Cortes
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1674–1683.
https://doi.org/10.1158/1078-0432.CCR-10-2922
Published: 31 March 2011
View article titled, Second-Generation Tyrosine Kinase Inhibitors: The Future of Frontline CML Therapy
Open the PDF for Second-Generation Tyrosine Kinase Inhibitors: The Future of Frontline CML Therapy in another window
Journal Articles

Alemtuzumab Therapy for Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia

Srdan Verstovsek, Ayalew Tefferi, Hagop Kantarjian, Taghi Manshouri, Raja Luthra, Animesh Pardanani, Alfonso Quintás-Cardama, Farhad Ravandi, Pat Ault, Carlos Bueso-Ramos, Jorge E. Cortes
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (1): 368–373.
https://doi.org/10.1158/1078-0432.CCR-08-1302
Published: 31 December 2008
View article titled, Alemtuzumab Therapy for Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia
Open the PDF for Alemtuzumab Therapy for Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia in another window
Journal Articles

Phase I Study of Alternate-Week Administration of Tipifarnib in Patients with Myelodysplastic Syndrome

Razelle Kurzrock, Hagop M. Kantarjian, Michelle A. Blascovich, Cindy Bucher, Srdan Verstovsek, John J. Wright, Susan R. Pilat, Jorge E. Cortes, Elihu H. Estey, Francis J. Giles, Miloslav Beran, Said M. Sebti
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 509–514.
https://doi.org/10.1158/1078-0432.CCR-07-1532
Published: 25 January 2008
View article titled, Phase I Study of Alternate-Week Administration of Tipifarnib in Patients with Myelodysplastic Syndrome
Open the PDF for Phase I Study of Alternate-Week Administration of Tipifarnib in Patients with Myelodysplastic Syndrome in another window
Journal Articles

Phase I Study of Oral Topotecan in Hematological Malignancies

Miloslav Beran, Susan O’Brien, Deborah A. Thomas, Hai T. Tran, Jorge E. Cortes-Franco, Francis Giles, Elihu Estey, Hagop M. Kantarjian
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (11): 4084–4091.
Published: 30 September 2003
View article titled, Phase I Study of Oral Topotecan in Hematological Malignancies
Open the PDF for Phase I Study of Oral Topotecan in Hematological Malignancies in another window
Journal Articles

Development of Varicella-Zoster Virus Infection in Patients with Chronic Myelogenous Leukemia Treated with Imatinib Mesylate

Gloria N. Mattiuzzi, Jorge E. Cortes, Moshe Talpaz, James Reuben, Mary Beth Rios, Jianjin Shan, Dimitrios Kontoyiannis, Francis J. Giles, Issam Raad, Srdan Verstovsek, Alessandra Ferrajoli, Hagop M. Kantarjian
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (3): 976–980.
Published: 01 March 2003
View article titled, Development of Varicella-Zoster Virus Infection in Patients with Chronic Myelogenous Leukemia Treated with Imatinib Mesylate
Open the PDF for Development of Varicella-Zoster Virus Infection in Patients with Chronic Myelogenous Leukemia Treated with Imatinib Mesylate in another window
Journal Articles

Imatinib Mesylate for Philadelphia Chromosome-positive, Chronic-Phase Myeloid Leukemia after Failure of Interferon-α: Follow-Up Results

Hagop M. Kantarjian, Moshe Talpaz, Susan O’Brien, Terry L. Smith, Francis J. Giles, Stefan Faderl, Deborah A. Thomas, Guillermo Garcia-Manero, Jean-Pierre J. Issa, Michael Andreeff, Steven M. Kornblau, Charles Koller, Milosav Beran, Michael Keating, Mary Beth Rios, Jenny Shan, Debra Resta, Renaud Capdeville, Kimberly Hayes, Maher Albitar, Emil J. Freireich, Jorge E. Cortes
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2177–2187.
Published: 01 July 2002
View article titled, Imatinib Mesylate for Philadelphia Chromosome-positive, Chronic-Phase Myeloid Leukemia after Failure of Interferon-α: <subtitle>Follow-Up Results</subtitle>
Open the PDF for Imatinib Mesylate for Philadelphia Chromosome-positive, Chronic-Phase Myeloid Leukemia after Failure of Interferon-α: <subtitle>Follow-Up Results</subtitle> in another window
Journal Articles

Phase I and Pharmacokinetic Study of DX-8951f (Exatecan Mesylate), a Hexacyclic Camptothecin, on a Daily-Times-Five Schedule in Patients with Advanced Leukemia

Francis J. Giles, Jorge E. Cortes, Deborah A. Thomas, Guillermo Garcia-Manero, Stephan Faderl, Sima Jeha, Robert L. De Jager, Hagop M. Kantarjian
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2134–2141.
Published: 01 July 2002
View article titled, Phase I and Pharmacokinetic Study of DX-8951f (Exatecan Mesylate), a Hexacyclic Camptothecin, on a Daily-Times-Five Schedule in Patients with Advanced Leukemia
Open the PDF for Phase I and Pharmacokinetic Study of DX-8951f (Exatecan Mesylate), a Hexacyclic Camptothecin, on a Daily-Times-Five Schedule in Patients with Advanced Leukemia in another window
Journal Articles

Treatment of Philadelphia Chromosome-positive, Accelerated-phase Chronic Myelogenous Leukemia with Imatinib Mesylate

Hagop M. Kantarjian, Susan O’Brien, Jorge E. Cortes, Terry L. Smith, Mary Beth Rios, Jianqin Shan, Ying Yang, Francis J. Giles, Deborah A. Thomas, Stefan Faderl, Guillermo Garcia-Manero, Sima Jeha, William Wierda, Jean-Pierre J. Issa, Steven M. Kornblau, Michael Keating, Debra Resta, Renaud Capdeville, Moshe Talpaz
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2167–2176.
Published: 01 July 2002
View article titled, Treatment of Philadelphia Chromosome-positive, Accelerated-phase Chronic Myelogenous Leukemia with Imatinib Mesylate
Open the PDF for Treatment of Philadelphia Chromosome-positive, Accelerated-phase Chronic Myelogenous Leukemia with Imatinib Mesylate in another window